{"name": "Lotus Tissue Repair",
 "permalink": "lotus-tissue-repair",
 "crunchbase_url": "http://www.crunchbase.com/company/lotus-tissue-repair",
 "homepage_url": "http://www.lotustissuerepair.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "lotus_info@lotustr.com",
 "phone_number": "1-617-674-7610",
 "description": "",
 "created_at": "Thu Jun 30 11:49:55 UTC 2011",
 "updated_at": "Thu Jun 30 11:54:18 UTC 2011",
 "overview": "\u003Cp\u003ELotus Tissue Repair is developing its proprietary recombinant human collagen Type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       53],
      "assets/images/resized/0014/1937/141937v1-max-150x150.jpg"],
     [[199,
       71],
      "assets/images/resized/0014/1937/141937v1-max-250x250.jpg"],
     [[199,
       71],
      "assets/images/resized/0014/1937/141937v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$26M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://financial.businessinsider.com/siliconalleymedia.clusterstock/news/read?GUID=18857212",
    "source_description": "Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystrophic Epidermolysis Bullosa ",
    "raised_amount": 26000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Third Rock Ventures",
         "permalink": "third-rock-ventures-2",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0005/0700/50700v1-max-150x150.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-250x250.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Mifflin Place",
    "address2": "Suite 400",
    "zip_code": "02138",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        91],
       "assets/images/resized/0014/1938/141938v1-max-150x150.jpg"],
      [[250,
        152],
       "assets/images/resized/0014/1938/141938v1-max-250x250.jpg"],
      [[450,
        273],
       "assets/images/resized/0014/1938/141938v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}